2016 Q4 Form 10-K Financial Statement
#000117184317001588 Filed on March 17, 2017
Income Statement
Concept | 2016 Q4 | 2015 Q4 | 2015 Q3 |
---|---|---|---|
Revenue | $26.42M | $28.37M | $25.73M |
YoY Change | -6.89% | -6.57% | 1.11% |
Cost Of Revenue | $14.31M | $15.45M | $14.01M |
YoY Change | -7.35% | -6.39% | -0.01% |
Gross Profit | $12.11M | $12.92M | $11.73M |
YoY Change | -6.34% | -6.77% | 2.48% |
Gross Profit Margin | 45.83% | 45.56% | 45.57% |
Selling, General & Admin | $10.26M | $10.30M | $10.03M |
YoY Change | -0.39% | 7.63% | 21.72% |
% of Gross Profit | 84.76% | 79.7% | 85.56% |
Research & Development | $1.160M | $1.530M | $1.426M |
YoY Change | -24.18% | -1.92% | 34.66% |
% of Gross Profit | 9.58% | 11.84% | 12.16% |
Depreciation & Amortization | $990.0K | $1.270M | $1.060M |
YoY Change | -22.05% | 16.51% | 13.98% |
% of Gross Profit | 8.18% | 9.83% | 9.04% |
Operating Expenses | $13.23M | $12.81M | $12.50M |
YoY Change | 3.26% | 9.1% | 24.8% |
Operating Profit | -$1.123M | $113.0K | -$775.0K |
YoY Change | -1093.81% | -94.67% | -154.39% |
Interest Expense | $170.0K | -$160.0K | $204.0K |
YoY Change | -206.25% | -23.81% | -14.64% |
% of Operating Profit | -141.59% | ||
Other Income/Expense, Net | $135.0K | -$434.0K | -$321.0K |
YoY Change | -131.11% | -54.27% | -31.56% |
Pretax Income | -$988.0K | -$321.0K | -$1.096M |
YoY Change | 207.79% | -127.39% | -214.64% |
Income Tax | $332.0K | $16.82M | -$249.0K |
% Of Pretax Income | |||
Net Earnings | -$1.320M | -$17.14M | -$847.0K |
YoY Change | -92.3% | 90110.53% | -233.81% |
Net Earnings / Revenue | -5.0% | -60.42% | -3.29% |
Basic Earnings Per Share | -$0.04 | -$0.51 | -$0.02 |
Diluted Earnings Per Share | -$0.04 | -$0.51 | -$0.02 |
COMMON SHARES | |||
Basic Shares Outstanding | 34.37M shares | 33.94M shares | 33.93M shares |
Diluted Shares Outstanding | 33.93M shares |
Balance Sheet
Concept | 2016 Q4 | 2015 Q4 | 2015 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $5.600M | $6.700M | $6.100M |
YoY Change | -16.42% | -52.48% | -77.15% |
Cash & Equivalents | $5.596M | $6.744M | $6.090M |
Short-Term Investments | |||
Other Short-Term Assets | $4.175M | $3.873M | $5.070M |
YoY Change | 7.8% | -18.33% | 24.82% |
Inventory | $19.96M | $22.34M | $23.01M |
Prepaid Expenses | |||
Receivables | $15.75M | $17.55M | $15.59M |
Other Receivables | $4.200M | $3.900M | $5.100M |
Total Short-Term Assets | $45.47M | $50.55M | $52.32M |
YoY Change | -10.04% | -11.42% | -19.5% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $4.296M | $5.902M | $5.934M |
YoY Change | -27.21% | 13.72% | 44.41% |
Goodwill | $38.03M | $40.36M | $40.86M |
YoY Change | -5.76% | 1.34% | 13.69% |
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $128.0K | $152.0K | $349.0K |
YoY Change | -15.79% | -60.0% | -2.79% |
Total Long-Term Assets | $62.29M | $69.50M | $81.23M |
YoY Change | -10.37% | -11.86% | 14.21% |
TOTAL ASSETS | |||
Total Short-Term Assets | $45.47M | $50.55M | $52.32M |
Total Long-Term Assets | $62.29M | $69.50M | $81.23M |
Total Assets | $107.8M | $120.1M | $133.6M |
YoY Change | -10.23% | -11.67% | -1.89% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $6.196M | $8.782M | $6.322M |
YoY Change | -29.45% | 39.53% | 23.96% |
Accrued Expenses | $4.550M | $4.021M | $3.840M |
YoY Change | 13.16% | -9.68% | -7.07% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $2.400M | $2.400M | $5.000M |
YoY Change | 0.0% | -52.0% | 0.0% |
Total Short-Term Liabilities | $14.60M | $19.32M | $17.27M |
YoY Change | -24.44% | 6.76% | 10.51% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $11.37M | $16.37M | $15.15M |
YoY Change | -30.51% | -0.49% | -16.76% |
Other Long-Term Liabilities | $3.200M | $3.000M | $4.600M |
YoY Change | 6.67% | -34.78% | -14.81% |
Total Long-Term Liabilities | $11.37M | $16.37M | $15.15M |
YoY Change | -30.51% | -0.49% | -16.76% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $14.60M | $19.32M | $17.27M |
Total Long-Term Liabilities | $11.37M | $16.37M | $15.15M |
Total Liabilities | $35.57M | $42.45M | $39.27M |
YoY Change | -16.21% | 4.95% | -0.21% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$116.0M | -$111.7M | -$94.58M |
YoY Change | 3.86% | 20.54% | 2.06% |
Common Stock | $215.6M | $211.9M | $211.1M |
YoY Change | 1.74% | 2.33% | 2.57% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | 7.746M shares | 7.746M shares | 7.746M shares |
Shareholders Equity | $72.20M | $77.60M | $94.29M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $107.8M | $120.1M | $133.6M |
YoY Change | -10.23% | -11.67% | -1.89% |
Cashflow Statement
Concept | 2016 Q4 | 2015 Q4 | 2015 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.320M | -$17.14M | -$847.0K |
YoY Change | -92.3% | 90110.53% | -233.81% |
Depreciation, Depletion And Amortization | $990.0K | $1.270M | $1.060M |
YoY Change | -22.05% | 16.51% | 13.98% |
Cash From Operating Activities | $1.720M | $1.770M | -$80.00K |
YoY Change | -2.82% | 40.48% | -113.33% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$530.0K | -$680.0K | -$660.0K |
YoY Change | -22.06% | -13.92% | 37.5% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $1.420M | $0.00 | -$10.00K |
YoY Change | -100.0% | ||
Cash From Investing Activities | $890.0K | -$680.0K | -$670.0K |
YoY Change | -230.88% | -94.5% | 39.58% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -1.210M | -1.160M | -410.0K |
YoY Change | 4.31% | 6.42% | -130.15% |
NET CHANGE | |||
Cash From Operating Activities | 1.720M | 1.770M | -80.00K |
Cash From Investing Activities | 890.0K | -680.0K | -670.0K |
Cash From Financing Activities | -1.210M | -1.160M | -410.0K |
Net Change In Cash | 1.400M | -70.00K | -1.160M |
YoY Change | -2100.0% | -99.43% | -178.38% |
FREE CASH FLOW | |||
Cash From Operating Activities | $1.720M | $1.770M | -$80.00K |
Capital Expenditures | -$530.0K | -$680.0K | -$660.0K |
Free Cash Flow | $2.250M | $2.450M | $580.0K |
YoY Change | -8.16% | 19.51% | -46.3% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2015 | us-gaap |
Defined Benefit Plan Foreign Currency Exchange Rate Changes Plan Assets
DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets
|
-758000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Foreign Currency Exchange Rate Changes Plan Assets
DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets
|
-3095000 | USD |
CY2015Q4 | us-gaap |
Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
|
-2815000 | USD |
CY2015Q4 | us-gaap |
Defined Benefit Plan Amounts Recognized In Balance Sheet
DefinedBenefitPlanAmountsRecognizedInBalanceSheet
|
-2280000 | USD |
CY2015Q4 | hbio |
Deferred Income Taxes On Pension Liabilities
DeferredIncomeTaxesOnPensionLiabilities
|
535000 | USD |
CY2015Q4 | us-gaap |
Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
|
2815000 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
|
0.0357 | pure |
CY2014 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
|
0.0415 | pure |
CY2015 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
|
0.0443 | pure |
CY2016 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
|
0 | pure |
CY2015 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
|
0 | pure |
CY2016 | hbio |
Service Cost For Defined Benefit Plan
ServiceCostForDefinedBenefitPlan
|
0 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
|
70000 | USD |
CY2016 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-2458000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
|
0.0262 | pure |
CY2015 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-2280000 | USD |
CY2014 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
|
0.0443 | pure |
CY2016 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
|
0.0468 | pure |
CY2014 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
|
0 | pure |
CY2015 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate Support Methodology And Source Data
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData
|
The discount rate assumptions used for pension accounting reflect the prevailing rates available on high-quality, fixed-income debt instruments with terms that match the average expected duration of the Company’s defined benefit pension plan obligations. The Company uses the iBoxx AA 15yr+ index, which matches the average duration of its pension plan liability of approximately 15 years. With the current base of assets in the pension plans, a one percent increase/decrease in the discount rate assumption would decrease/increase annual pension expense by approximately $##D<pen-disc-rate-change>. | |
CY2015Q4 | us-gaap |
Defined Benefit Plan Weighted Average Asset Allocations
DefinedBenefitPlanWeightedAverageAssetAllocations
|
1 | pure |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
945000 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.1 | |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
-413864 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
3.84 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5022186 | shares |
CY2016Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
3.94 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
2.8 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
1072653 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
-301520 | shares |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
5.29 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
-34576 | shares |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
5.56 | |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
5.56 | |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.5578 | pure |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.018 | pure |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y9M3D | |
CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2156000 | USD |
CY2016Q4 | hbio |
Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
|
0.2 | pure |
CY2015 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.57 | |
CY2016 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-2413000 | USD |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
|
0.85 | pure |
CY2016Q4 | hbio |
Employee Stock Purchase Plan Shares Authorized
EmployeeStockPurchasePlanSharesAuthorized
|
750000 | shares |
us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
725239 | shares | |
CY2016Q4 | hbio |
Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold
LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold
|
6000000 | USD |
CY2016Q4 | hbio |
Lender Approval To Fund Acquisition With Equity In Excess Of Threshold
LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold
|
10000000 | USD |
CY2009Q3 | hbio |
Previous Approved Credit Facility
PreviousApprovedCreditFacility
|
20000000 | USD |
CY2013Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
50000000 | USD |
CY2013Q1 | hbio |
Ddtl Threshold For Dollar For Dollar Reduction In Revolving Line
DdtlThresholdForDollarForDollarReductionInRevolvingLine
|
10000000 | USD |
CY2009Q3 | hbio |
Interest Rate In Excess Of Libor On Credit Facility
InterestRateInExcessOfLiborOnCreditFacility
|
0.03 | pure |
CY2016Q4 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
8700000 | USD |
CY2013Q4 | hbio |
Transferof Delayed Draw Down Term Loan Capacity To Revolver Capacity
TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity
|
5000000 | USD |
CY2016 | hbio |
Derivative Interest Rate Swap Effective Percentage
DerivativeInterestRateSwapEffectivePercentage
|
1 | pure |
CY2015 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
-4000 | USD |
CY2014 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
-67000 | USD |
CY2014 | us-gaap |
Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
|
56000 | USD |
CY2015 | us-gaap |
Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
|
4000 | USD |
CY2015Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
310000 | USD |
CY2014Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
328000 | USD |
CY2015Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
17547000 | USD |
CY2015Q4 | us-gaap |
Assets
Assets
|
120050000 | USD |
CY2015Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
3873000 | USD |
CY2015Q4 | us-gaap |
Inventory Net
InventoryNet
|
22343000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
995000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
20872000 | USD |
CY2015Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
310000 | USD |
CY2015Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
80000000 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
41724772 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
33979265 | shares |
CY2015Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
7745507 | shares |
CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2015Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
42000 | USD |
CY2015Q4 | us-gaap |
Assets Current
AssetsCurrent
|
50549000 | USD |
CY2015Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
152000 | USD |
CY2015Q4 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
2364000 | USD |
CY2015Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8782000 | USD |
CY2015Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
752000 | USD |
CY2015Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
290000 | USD |
CY2015Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4021000 | USD |
CY2015Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
868000 | USD |
CY2015Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
19323000 | USD |
CY2015Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
16369000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
3775000 | USD |
CY2015Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
2985000 | USD |
CY2015Q4 | us-gaap |
Liabilities
Liabilities
|
42452000 | USD |
CY2015Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2015Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
416000 | USD |
CY2015Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
211457000 | USD |
CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-111723000 | USD |
CY2015Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-11884000 | USD |
CY2015Q4 | us-gaap |
Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
|
10668000 | USD |
CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
120050000 | USD |
CY2016 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >(b)</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >Use of Estimates</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' >The preparation of financial</font><font style='font-family:Times New Roman;font-size:10pt;' > statements in conformity with accounting principles generally accepted in the United States requires the use of management estimates. Such estimates include the determination and establishment of certain accruals and provisions, including those for invent</font><font style='font-family:Times New Roman;font-size:10pt;' >ory excess and </font><font style='font-family:Times New Roman;font-size:10pt;' >obsolescence, </font><font style='font-family:Times New Roman;font-size:10pt;' >income tax and reserves for bad debts. In addition, certain estimates are required in order to determine the value of assets and liabilities associated with acquisitions, as well as the Company’s defined benefit pension obligations</font><font style='font-family:Times New Roman;font-size:10pt;' >. Estimates are also required to e</font><font style='font-family:Times New Roman;font-size:10pt;' >valuate the value and recoverability of existing long-lived and intangible assets, including goodwill. On an ongoing basis, the Company reviews its estimates based upon currently available information. Actual results could differ materially from those esti</font><font style='font-family:Times New Roman;font-size:10pt;' >mates.</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ></p></div> | |
CY2014 | us-gaap |
Revenues
Revenues
|
108663000 | USD |
CY2014 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
59319000 | USD |
CY2014 | us-gaap |
Gross Profit
GrossProfit
|
49344000 | USD |
CY2014 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
18225000 | USD |
CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
16826000 | USD |
CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4880000 | USD |
CY2014 | us-gaap |
Restructuring Charges
RestructuringCharges
|
1027000 | USD |
CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
42726000 | USD |
CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
6618000 | USD |
CY2014 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-150000 | USD |
CY2014 | us-gaap |
Interest Expense
InterestExpense
|
990000 | USD |
CY2014 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
74000 | USD |
CY2014 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1135000 | USD |
CY2014 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2201000 | USD |
CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2062000 | USD |
CY2014 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.07 | |
CY2015 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
59941000 | USD |
CY2015 | us-gaap |
Gross Profit
GrossProfit
|
48723000 | USD |
CY2015 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
20577000 | USD |
CY2015 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
19832000 | USD |
CY2015 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6420000 | USD |
CY2016 | us-gaap |
Revenues
Revenues
|
104521000 | USD |
CY2016 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
56106000 | USD |
CY2016 | us-gaap |
Gross Profit
GrossProfit
|
48415000 | USD |
CY2016 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
20486000 | USD |
CY2016 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
20950000 | USD |
CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5392000 | USD |
CY2015 | us-gaap |
Restructuring Charges
RestructuringCharges
|
788000 | USD |
CY2014 | us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
810000 | USD |
CY2016 | us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
0 | USD |
CY2015 | us-gaap |
Operating Expenses
OperatingExpenses
|
50436000 | USD |
CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1713000 | USD |
CY2016 | us-gaap |
Operating Expenses
OperatingExpenses
|
51412000 | USD |
CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2997000 | USD |
CY2015 | us-gaap |
Interest Expense
InterestExpense
|
854000 | USD |
CY2015 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1259000 | USD |
CY2015 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1895000 | USD |
CY2016 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
737000 | USD |
CY2016 | us-gaap |
Interest Expense
InterestExpense
|
642000 | USD |
CY2016 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
3000 | USD |
CY2016 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-179000 | USD |
CY2016 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-81000 | USD |
CY2015 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
15431000 | USD |
CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1229000 | USD |
CY2015 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.57 | |
CY2016 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.13 | |
CY2016 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.13 | |
CY2014 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.07 | |
CY2015 | us-gaap |
Depreciation
Depreciation
|
1745000 | USD |
CY2014 | us-gaap |
Depreciation
Depreciation
|
1253000 | USD |
CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2355000 | USD |
CY2016 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
0 | USD |
CY2015 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-25000 | USD |
CY2014 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
810000 | USD |
CY2016 | hbio |
Non Cash Restructuring Charge
NonCashRestructuringCharge
|
-27000 | USD |
CY2015 | hbio |
Non Cash Restructuring Charge
NonCashRestructuringCharge
|
-85000 | USD |
CY2014 | hbio |
Non Cash Restructuring Charge
NonCashRestructuringCharge
|
-120000 | USD |
CY2016 | hbio |
Amortization Of Catalog Costs
AmortizationOfCatalogCosts
|
20000 | USD |
CY2015 | hbio |
Amortization Of Catalog Costs
AmortizationOfCatalogCosts
|
9000 | USD |
CY2014 | hbio |
Amortization Of Catalog Costs
AmortizationOfCatalogCosts
|
47000 | USD |
CY2016 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
309000 | USD |
CY2015 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-7000 | USD |
CY2014 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-67000 | USD |
CY2016 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2722000 | USD |
CY2015 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2819000 | USD |
CY2014 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2578000 | USD |
CY2016 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
91000 | USD |
CY2015 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
86000 | USD |
CY2014 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
61000 | USD |
CY2016 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-279000 | USD |
CY2015 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
15116000 | USD |
CY2014 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
1412000 | USD |
CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-566000 | USD |
CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
735000 | USD |
CY2016 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-1248000 | USD |
CY2015 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1223000 | USD |
CY2016 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
658000 | USD |
CY2014 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
370000 | USD |
CY2015 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
2577000 | USD |
CY2014 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
1069000 | USD |
CY2016 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-195000 | USD |
CY2015 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-311000 | USD |
CY2015 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1511000 | USD |
CY2014 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-345000 | USD |
CY2016 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-187000 | USD |
CY2015 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
120000 | USD |
CY2014 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
28000 | USD |
CY2016 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
727000 | USD |
CY2015 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-1786000 | USD |
CY2014 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-836000 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
5383000 | USD |
CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
705000 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
4351000 | USD |
CY2016 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
-1445000 | USD |
CY2015 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
-2960000 | USD |
CY2014 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
-2005000 | USD |
CY2016 | hbio |
Additions To Catalog Costs
AdditionsToCatalogCosts
|
-34000 | USD |
CY2015 | hbio |
Additions To Catalog Costs
AdditionsToCatalogCosts
|
-18000 | USD |
CY2014 | hbio |
Additions To Catalog Costs
AdditionsToCatalogCosts
|
0 | USD |
CY2016 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | USD |
CY2015 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
6000 | USD |
CY2014 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
1141000 | USD |
CY2016 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | USD |
CY2015 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
4545000 | USD |
CY2014 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
12653000 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-62000 | USD |
CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-7517000 | USD |
CY2016 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
9050000 | USD |
CY2014 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
5500000 | USD |
CY2016 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
4000000 | USD |
CY2015 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
5800000 | USD |
CY2014 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
2200000 | USD |
CY2016 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
CY2015 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
32000 | USD |
CY2014 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
CY2016 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
182000 | USD |
CY2015 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2042000 | USD |
CY2014 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2066000 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-4868000 | USD |
CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-540000 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1234000 | USD |
CY2016 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-1601000 | USD |
CY2015 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-38000 | USD |
CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-7390000 | USD |
CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-11637000 | USD |
CY2016 | us-gaap |
Interest Paid
InterestPaid
|
620000 | USD |
CY2014 | us-gaap |
Interest Paid
InterestPaid
|
997000 | USD |
CY2015 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
963000 | USD |
CY2014 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
843000 | USD |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
25771000 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
2160000 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
228000 | USD |
CY2014 | hbio |
Shares Withheld For Taxes Value
SharesWithheldForTaxesValue
|
327000 | USD |
CY2014 | us-gaap |
Stockholders Equity Other Shares
StockholdersEquityOtherShares
|
233000 | shares |
CY2014 | hbio |
Shares Withheld For Taxes
SharesWithheldForTaxes
|
62000 | shares |
CY2016 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-4606000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-4936000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-5941000 | USD |
CY2016 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
-29000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
-85000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
-99000 | USD |
CY2016 | us-gaap |
Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
10000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
8000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
31000 | USD |
CY2016 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
|
-252000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
|
-248000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
|
-207000 | USD |
CY2016 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
|
430000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
|
-1029000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
|
-114000 | USD |
CY2016 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
178000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
-1277000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
-321000 | USD |
CY2016 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-4774000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-3651000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-5589000 | USD |
CY2016 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-9081000 | USD |
CY2015 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-22690000 | USD |
CY2014 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3234000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
|
58000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
|
241000 | USD |
CY2015Q4 | us-gaap |
Goodwill
Goodwill
|
40357000 | USD |
CY2015Q4 | us-gaap |
Secured Debt
SecuredDebt
|
18733000 | USD |
CY2016Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
2450000 | USD |
CY2016Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
11400000 | USD |
CY2016Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
0 | USD |
CY2014 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
33236569 | shares |
CY2015Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
12811000 | USD |
CY2015Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
113000 | USD |
CY2016Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
0 | USD |
CY2016Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
0 | USD |
CY2016Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
13850000 | USD |
CY2016Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1468000 | USD |
CY2015Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1264000 | USD |
CY2016Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1105000 | USD |
CY2015Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1055000 | USD |
CY2016Q4 | us-gaap |
Restructuring Reserve Current
RestructuringReserveCurrent
|
0 | USD |
CY2015Q4 | us-gaap |
Restructuring Reserve Current
RestructuringReserveCurrent
|
132000 | USD |
CY2016Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
193000 | USD |
CY2015Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
147000 | USD |
CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1784000 | USD |
CY2015Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1423000 | USD |
CY2016Q4 | hbio |
Total Accrued Expenses
TotalAccruedExpenses
|
4550000 | USD |
CY2015Q4 | hbio |
Total Accrued Expenses
TotalAccruedExpenses
|
4021000 | USD |
CY2016 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
790000 | USD |
CY2015 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
677000 | USD |
CY2014 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
424000 | USD |
CY2016 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
960000 | USD |
CY2015 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
673000 | USD |
CY2014 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
451000 | USD |
CY2016 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
103000 | USD |
CY2015 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-840000 | USD |
CY2014 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-182000 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-1046000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-1227000 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
1503000 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
165000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
-12000 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
-364000 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-93000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
82000 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
22000 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
110000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-161000 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
67000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
0 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
0 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
-169000 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
-385000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
16401000 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
1346000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-9000 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-34000 | USD |
CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-3107000 | USD |
CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-3331000 | USD |
CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
1846000 | USD |
CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
29000 | USD |
CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-277000 | USD |
CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
2571000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
45000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
1447000 | USD |
CY2015Q4 | hbio |
Deferred Tax Assets Operating Loss And Credits Carryforwards
DeferredTaxAssetsOperatingLossAndCreditsCarryforwards
|
14456000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
107000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
|
535000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
|
2987000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
|
588000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
23402000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
-18823000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
4579000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
0 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
655000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
9563000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
-4984000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
170000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
1336000 | USD |
CY2016Q4 | hbio |
Deferred Tax Assets Operating Loss And Credits Carryforwards
DeferredTaxAssetsOperatingLossAndCreditsCarryforwards
|
12586000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
0 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
|
631000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
|
3262000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
|
23000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
20089000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
-17840000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
2249000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
0 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
349000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
7509000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
-5260000 | USD |
CY2014Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
250000 | USD |
CY2015 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
35000 | USD |
CY2016 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
62000 | USD |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6744000 | USD |
CY2015 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
2630000 | USD |
CY2015 | us-gaap |
Stockholders Equity Other Shares
StockholdersEquityOtherShares
|
237000 | shares |
CY2015 | hbio |
Shares Withheld For Taxes
SharesWithheldForTaxes
|
652000 | shares |
CY2015 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
208000 | USD |
CY2015 | hbio |
Shares Withheld For Taxes Value
SharesWithheldForTaxesValue
|
773000 | USD |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
94485000 | USD |
CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
77598000 | USD |
CY2013Q4 | us-gaap |
Shares Issued
SharesIssued
|
39385000 | shares |
CY2016 | us-gaap |
Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
|
0 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
|
0 | USD |
CY2014 | us-gaap |
Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
|
0 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
|
711000 | USD |
CY2014 | us-gaap |
Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
|
893000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
|
683000 | USD |
CY2016Q1 | us-gaap |
Gross Profit
GrossProfit
|
12945000 | USD |
CY2016Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
13166000 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
|
668000 | USD |
CY2014 | us-gaap |
Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
|
649000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
|
-304000 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
|
-306000 | USD |
CY2014 | us-gaap |
Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
|
-259000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
|
0 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
|
0 | USD |
CY2014 | us-gaap |
Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
|
0 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
253000 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
349000 | USD |
CY2014 | us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
503000 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
|
-1360000 | USD |
CY2015 | hbio |
Service Cost For Defined Benefit Plan
ServiceCostForDefinedBenefitPlan
|
0 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation
DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
|
-918000 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
752000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Benefits Paid
DefinedBenefitPlanBenefitsPaid
|
-982000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
|
632000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
|
4636000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
|
3868000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
694000 | USD |
CY2014Q4 | us-gaap |
Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
|
16724000 | USD |
CY2015Q4 | us-gaap |
Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
|
15767000 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
|
19214000 | USD |
CY2014Q4 | us-gaap |
Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
|
21170000 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
|
-2962000 | USD |
CY2016Q4 | hbio |
Deferred Income Taxes On Pension Liabilities
DeferredIncomeTaxesOnPensionLiabilities
|
504000 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
|
2962000 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Plan Amounts Recognized In Balance Sheet
DefinedBenefitPlanAmountsRecognizedInBalanceSheet
|
-2458000 | USD |
CY2014 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
-337000 | USD |
CY2016Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
21767000 | USD |
CY2015Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
26774000 | USD |
CY2016Q4 | hbio |
Segment Reporting Information Net Assets1
SegmentReportingInformationNetAssets1
|
72196000 | USD |
CY2015Q4 | hbio |
Segment Reporting Information Net Assets1
SegmentReportingInformationNetAssets1
|
77598000 | USD |
CY2014 | hbio |
Valuation Allowances And Reserves Currency Translation
ValuationAllowancesAndReservesCurrencyTranslation
|
-19000 | USD |
CY2015 | hbio |
Valuation Allowances And Reserves Currency Translation
ValuationAllowancesAndReservesCurrencyTranslation
|
-18000 | USD |
CY2013Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
358000 | USD |
CY2015Q3 | us-gaap |
Revenues
Revenues
|
25731000 | USD |
CY2015Q4 | us-gaap |
Revenues
Revenues
|
28370000 | USD |
CY2015Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
14005000 | USD |
CY2015Q4 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
15446000 | USD |
CY2015Q3 | us-gaap |
Gross Profit
GrossProfit
|
11726000 | USD |
CY2015Q4 | us-gaap |
Gross Profit
GrossProfit
|
12924000 | USD |
CY2015Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
12501000 | USD |
CY2015Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-775000 | USD |
CY2015Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-321000 | USD |
CY2015Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-434000 | USD |
CY2015Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1096000 | USD |
CY2015Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-321000 | USD |
CY2015Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-249000 | USD |
CY2015Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
16819000 | USD |
CY2015Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-847000 | USD |
CY2015Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-17140000 | USD |
CY2015Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
CY2015Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.51 | |
CY2015Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
CY2015Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.51 | |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
|
2246000 | USD |
CY2016 | hbio |
Minimun Percentage Of Term Loan And Delayed Draw Term Loan On Which Interest Rate Required To Be Fixed
MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed
|
0.5 | pure |
CY2014 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
32170683 | shares |
CY2016 | us-gaap |
Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation
DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
|
-3654000 | USD |
CY2015Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5902000 | USD |
CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
18904000 | USD |
CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
14608000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
1600000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
1614000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
1489000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
1284000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
1087000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
2919000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
9993000 | USD |
CY2016Q4 | us-gaap |
Revenues
Revenues
|
26415000 | USD |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
2400000 | USD |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
2200000 | USD |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
2100000 | USD |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
2100000 | USD |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
2000000 | USD |
CY2016Q4 | hbio |
Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
|
39241000 | USD |
CY2016Q4 | hbio |
Total Intangible Assets
TotalIntangibleAssets
|
84882000 | USD |
CY2015 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
-81000 | USD |
CY2015 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
-24000 | USD |
CY2016Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
193000 | USD |
CY2016 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
-97000 | USD |
CY2016 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
143000 | USD |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14134000 | USD |
CY2016 | us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
-5065000 | USD |
CY2016 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
-291000 | USD |
CY2016Q4 | us-gaap |
Secured Debt
SecuredDebt
|
13746000 | USD |
CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
21920000 | USD |
CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
16018000 | USD |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
45641000 | USD |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-28170000 | USD |
CY2015Q4 | hbio |
Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
|
41580000 | USD |
CY2015Q4 | hbio |
Total Intangible Assets
TotalIntangibleAssets
|
89159000 | USD |
CY2014 | hbio |
Fair Value Impairment Of Pension Assets
FairValueImpairmentOfPensionAssets
|
0 | USD |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
1095190 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.4197 | pure |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.4097 | pure |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0129 | pure |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0172 | pure |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y3M16D | |
CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y6M0D | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3497000 | USD |
CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2755000 | USD |
CY2016 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
34211521 | shares |
CY2015 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
33592775 | shares |
CY2015 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2014 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1065886 | shares |
CY2016 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
34211521 | shares |
CY2015 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
33592775 | shares |
CY2016 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
81228 | shares |
CY2015Q2 | hbio |
Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan
IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan
|
2500000 | shares |
CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
17508929 | shares |
CY2015Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
80000 | USD |
CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
|
100000 | USD |
CY2016 | us-gaap |
Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
|
<div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >(s)</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >Recently </font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;' >Issued Accounting Pronouncements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >“Revenue from Contracts with Customers,”</font><font style='font-family:Times New Roman;font-size:10pt;' > a new accounting standard that provides for a comprehensive model to </font><font style='font-family:Times New Roman;font-size:10pt;' >use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within accounting principles generally accepted in the United States. Under this standard, revenue will be recognized to de</font><font style='font-family:Times New Roman;font-size:10pt;' >pict the transfer of promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. The Company expects to adopt this standard as of January 1, 2018 using the </font><font style='font-family:Times New Roman;font-size:10pt;' >modified retrospective approach. The Company intends to complete a comprehensive assessment of its contracts in 2017 concerning any </font><font style='font-family:Times New Roman;font-size:10pt;' >unique customer contract terms or transactions that could have implications to the timing of revenue recognition under the n</font><font style='font-family:Times New Roman;font-size:10pt;' >ew guidance</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company expects this undertaking will be complete in the second half of 2017.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >In July 2015, the FASB issued ASU 2015-11, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >Simplifying Measurement of Inventory</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >. The update requires measurement of most inventory “at the lower of cost and net</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > realizable value”, and applies to all entities that recognize inventory within the scope of ASC 330, except for inventory measured under the last-in, first-out (LIFO) method or the retail inventory method (RIM). ASU 2015-11 requires prospective applicatio</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >n and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2016. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company will adopt this standard effective January 1, 2017. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Adoption of this guidance is not expected to have a material impa</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ct on the Company's consolidated financial statements.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:22.5pt;' >In February 2016, the FASB issued ASU 2016-02, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Leases</font><font style='font-family:Times New Roman;font-size:10pt;' >, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >which is intended to improve financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the asse</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ts and liabilities for the rights and obligations created by lease terms of more than 12 months. The update is effective for fiscal years beginning after December 15, 2018. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The Company is evaluating the requirements of this guidance and has not yet determi</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ned the impact of the adoption on its consolidated financial position, results of operations and cash flows, however, </font><font style='font-family:Times New Roman;font-size:10pt;' >assets and liabilities will increase upon adoption for right-of-use assets and lease liabilities. The Company’s future commitments under l</font><font style='font-family:Times New Roman;font-size:10pt;' >ease obligations are summarized in Note 14.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:22.5pt;color:#000000;' >In June 2016, the FASB issued ASU 2016-13,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >Financial Instruments – Credit Losses (Topic 326), Measurement of credit losses on Financial Instruments.</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The update amends the FASB’s guidance on the impairment of </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >financial instruments. The ASU adds to U.S. GAAP an impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its est</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >imate of expected credit losses, which the FASB believes will result in more timely recognition of such losses. The ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is eva</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >luating the impact of ASU 2016-13 on its consolidated financial statements.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:22.5pt;color:#000000;' >In August 2016, the FASB issued ASU 2016-15,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >Classification of Certain Cash Receipts and Cash Payments (Topic 230)</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >which amends ASC 230,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >Statement of Cash Flows</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >to add or clarify </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >guidance on the classification of certain cash receipts and payments in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal year. The Company is evaluating</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > the impact of ASU 2016-13 on its consolidated financial statements.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >In March 2016, the FASB issued ASU 2016-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >, which simplifies the accounting for sh</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >are-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company will adopt this standard effective January 1, 2017. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Adoption of t</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >his guidance is not expected to have a material impact on the Company's consolidated financial statements; however, the impact in any given period will be dependent upon changes in the company's stock price, the volume of employee stock option exercises an</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >d the timing of service and performance-based restricted unit vestings.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Recently Adopted Accounting Pronouncements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:inherit;font-size:10pt;margin-left:24.5pt;' >In April 2015, the FASB issued ASU 2015-03, </font><font style='font-family:inherit;font-size:10pt;font-style:italic;' >Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs</font><font style='font-family:inherit;font-size:10pt;' >. Under </font><font style='font-family:inherit;font-size:10pt;' >this guidance, debt issuance costs related to a recognized debt liability should be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The provisions of this guidance are to be applied retrospectively and </font><font style='font-family:inherit;font-size:10pt;' >are effective for interim and annual periods beginning after December 15, 2015. The Company adopted this guidance as of January 1, 2016. The consolidated balance sheet as of December 31, 2015, included in these consolidated financial statements, reflects a</font><font style='font-family:inherit;font-size:10pt;' > restatement to reclassify unamortized deferred financing costs of approximately $0.2 million from other long-term assets to long-term debt. For deferred financing costs paid to secure long-term debt, the Company made a policy election to present such cost</font><font style='font-family:inherit;font-size:10pt;' >s as a direct deduction from the debt liability on the consolidated balance sheet.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In September 2015, the FASB issued ASU 2015-16</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >, Simplifying the Accounting for Measurement-Period Adjustments</font><font style='font-family:Times New Roman;font-size:10pt;' >. The update eliminates the requirement to retrospectively adju</font><font style='font-family:Times New Roman;font-size:10pt;' >st financial statements for measurement-period adjustments that occur in periods after a business combination. Under the update, measurement-period adjustments are to be calculated as if they were known at the acquisition date, but are recognized in the re</font><font style='font-family:Times New Roman;font-size:10pt;' >porting period in which they are determined. Additional disclosures are required about the impact on current-period earnings. ASU 2015-16 requires prospective application to adjustments of provisional amounts that occur after the effective date. The update</font><font style='font-family:Times New Roman;font-size:10pt;' > was effective for fiscal years beginning after December 15, 2015.  The Company adopted ASU 2015-16 on January 1, 2016. The adoption of ASU 2015-16 did not have a material impact on its consolidated financial statements.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In November 2015, the FASB issued </font><font style='font-family:Times New Roman;font-size:10pt;' >ASU 2015-17, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Balance Sheet Classification of Deferred Taxes</font><font style='font-family:Times New Roman;font-size:10pt;' >. The update requires all deferred income taxes to be presented on the balance sheet as noncurrent. The new guidance is intended to simplify financial reporting by eliminating the requirement to cl</font><font style='font-family:Times New Roman;font-size:10pt;' >assify deferred taxes between current and noncurrent. The update is effective for fiscal years beginning after December 15, 2016.  Early adoption is permitted at the beginning of an interim or annual period. As of January 1, 2016, the Company early adopted</font><font style='font-family:Times New Roman;font-size:10pt;' > the new guidance on a prospective basis and has presented all deferred tax assets and deferred tax liabilities as noncurrent in the consolidated balance sheet at December 31, 2016. Prior periods presented in the consolidated financial statements were not</font><font style='font-family:Times New Roman;font-size:10pt;' > retrospectively adjusted.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p></div> | |
CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
95468000 | USD |
CY2015Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
CY2015Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
CY2015Q2 | us-gaap |
Revenues
Revenues
|
28800000 | USD |
CY2015Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
16205000 | USD |
CY2015Q2 | us-gaap |
Gross Profit
GrossProfit
|
12595000 | USD |
CY2015Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
12496000 | USD |
CY2015Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
99000 | USD |
CY2015Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-526000 | USD |
CY2015Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-427000 | USD |
CY2015Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-776000 | USD |
CY2015Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
349000 | USD |
CY2015Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.01 | |
CY2015Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.01 | |
CY2014Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-8233000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
-3992000 | USD |
CY2015 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
-341000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
47579000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-26707000 | USD |
CY2014Q4 | us-gaap |
Goodwill
Goodwill
|
39822000 | USD |
CY2015 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
1618000 | USD |
CY2015 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-1455000 | USD |
CY2016 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1800000 | USD |
CY2015 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
2100000 | USD |
CY2014 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1700000 | USD |
CY2015 | us-gaap |
Revenues
Revenues
|
108664000 | USD |
CY2016 | us-gaap |
Defined Benefit Plan Contributions By Plan Participants
DefinedBenefitPlanContributionsByPlanParticipants
|
0 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
|
500000 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
|
400000 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
|
600000 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
|
500000 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
|
500000 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
|
3600000 | USD |
CY2016 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
600000 | USD |
CY2014 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
500000 | USD |
CY2013 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
500000 | USD |
CY2016 | us-gaap |
Defined Benefit Plans Estimated Future Employer Contributions In Next Fiscal Year
DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear
|
700000 | USD |
CY2015 | hbio |
Current Federal And State Income Tax Expense Benefit Continuing Operations
CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
|
-4000 | USD |
CY2014 | hbio |
Current Federal And State Income Tax Expense Benefit Continuing Operations
CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
|
27000 | USD |
CY2016 | hbio |
Deferred Federal And State Income Tax Expense Benefit Continuing Operations
DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
|
166000 | USD |
CY2015 | hbio |
Deferred Federal And State Income Tax Expense Benefit Continuing Operations
DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
|
15598000 | USD |
CY2014 | hbio |
Deferred Federal And State Income Tax Expense Benefit Continuing Operations
DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
|
1793000 | USD |
CY2016 | hbio |
Deferred Income Taxes Amount
DeferredIncomeTaxesAmount
|
269000 | USD |
CY2015 | hbio |
Deferred Income Taxes Amount
DeferredIncomeTaxesAmount
|
14758000 | USD |
CY2014 | hbio |
Deferred Income Taxes Amount
DeferredIncomeTaxesAmount
|
1611000 | USD |
CY2015Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
285000 | USD |
CY2016Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
406000 | USD |
CY2016Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
14018000 | USD |
CY2015 | hbio |
Business Acquisition Direct Acquisition Costs In Income Statement
BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement
|
1200000 | USD |
CY2014 | hbio |
Business Acquisition Direct Acquisition Costs In Income Statement
BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement
|
1100000 | USD |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6263112 | shares |
CY2014Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
3.42 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
313559 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6690845 | shares |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
306397 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
463973 | shares |
CY2013Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
3.42 | |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
4.3 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
4.32 | |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
254685 | shares |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
-237188 | shares |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
-10335 | shares |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
116400 | shares |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
-233098 | shares |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
-40878 | shares |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
4.12 | |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
4.36 | |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
4.18 | |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
4.67 | |
CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
3.08 | |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1115300 | shares |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
-847860 | shares |
CY2015 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
58823 | shares |
CY2014 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
57848 | shares |
CY2016Q4 | hbio |
Incentive Stock Options Granted To Date
IncentiveStockOptionsGrantedToDate
|
10218057 | shares |
CY2015Q4 | hbio |
Incentive Stock Options Granted To Date
IncentiveStockOptionsGrantedToDate
|
10218057 | shares |
CY2016Q4 | hbio |
Non Qualified Stock Options Granted To Date
NonQualifiedStockOptionsGrantedToDate
|
13131374 | shares |
CY2015Q4 | hbio |
Non Qualified Stock Options Granted To Date
NonQualifiedStockOptionsGrantedToDate
|
13088374 | shares |
CY2015 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5521283 | shares |
CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2526641 | shares |
CY2016Q4 | hbio |
In The Money Stock Options Exercisable At The Reporting Date
InTheMoneyStockOptionsExercisableAtTheReportingDate
|
914492 | shares |
CY2016Q4 | hbio |
Common Stock Market Value Per Share On Reporting Date
CommonStockMarketValuePerShareOnReportingDate
|
3.05 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
100000 | USD |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
800000 | USD |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
1800000 | USD |
CY2016 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y1M25D | |
CY2016Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
3800000 | USD |
CY2016 | hbio |
Annualized Estimated Forfeiture Rate
AnnualizedEstimatedForfeitureRate
|
0.0841 | pure |
CY2014 | hbio |
Annualized Estimated Forfeiture Rate
AnnualizedEstimatedForfeitureRate
|
0.0705 | pure |
CY2016 | hbio |
Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
|
1.21 | |
CY2014 | hbio |
Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
|
2.18 | |
CY2014 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
-102000 | USD |
CY2014 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
49000 | USD |
CY2016Q1 | us-gaap |
Revenues
Revenues
|
26963000 | USD |
CY2016Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-221000 | USD |
CY2016Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-222000 | USD |
CY2016Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-443000 | USD |
CY2016Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
193000 | USD |
CY2016Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
CY2016Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-636000 | USD |
CY2016Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
CY2016Q4 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
14310000 | USD |
CY2016Q4 | us-gaap |
Gross Profit
GrossProfit
|
12105000 | USD |
CY2016Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
13228000 | USD |
CY2016Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1123000 | USD |
CY2016Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
135000 | USD |
CY2016Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-988000 | USD |
CY2016Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
332000 | USD |
CY2016Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1320000 | USD |
CY2016Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
CY2016Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
CY2016Q2 | us-gaap |
Revenues
Revenues
|
26136000 | USD |
CY2016Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
14461000 | USD |
CY2016Q2 | us-gaap |
Gross Profit
GrossProfit
|
11675000 | USD |
CY2016Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
12515000 | USD |
CY2016Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-840000 | USD |
CY2016Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
73000 | USD |
CY2016Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-767000 | USD |
CY2016Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-54000 | USD |
CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-713000 | USD |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | pure |
CY2015Q4 | hbio |
Undistributed Foreign Earnings
UndistributedForeignEarnings
|
48700000 | USD |
CY2014Q4 | hbio |
Undistributed Foreign Earnings
UndistributedForeignEarnings
|
51900000 | USD |
CY2016Q4 | hbio |
Cash In Foreign Subsidiaries
CashInForeignSubsidiaries
|
4500000 | USD |
CY2015 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
16400000 | USD |
CY2016Q4 | hbio |
Net Operating Loss Carryforwards Subject To Annual Limitation
NetOperatingLossCarryforwardsSubjectToAnnualLimitation
|
4700000 | USD |
CY2016Q4 | hbio |
Net Operating Loss Carryforwards Annual Limitation
NetOperatingLossCarryforwardsAnnualLimitation
|
700000 | USD |
CY2015Q4 | hbio |
Cash Held In Foreign Subsidiaries Used For Foreign Capital Improvements
CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements
|
300000 | USD |
CY2016Q4 | hbio |
Tax Liability On Foreign Earnings Repatriated
TaxLiabilityOnForeignEarningsRepatriated
|
1200000 | USD |
CY2016 | us-gaap |
Foreign Earnings Repatriated
ForeignEarningsRepatriated
|
3500000 | USD |
CY2016Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
CY2016 | hbio |
Shares Withheld For Taxes Value
SharesWithheldForTaxesValue
|
185000 | USD |
CY2016 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
196000 | USD |
CY2016 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
171000 | USD |
CY2016 | us-gaap |
Stockholders Equity Other Shares
StockholdersEquityOtherShares
|
302000 | shares |
CY2016 | hbio |
Shares Withheld For Taxes
SharesWithheldForTaxes
|
296000 | shares |
CY2014Q4 | us-gaap |
Shares Issued
SharesIssued
|
40309000 | shares |
CY2015Q4 | us-gaap |
Shares Issued
SharesIssued
|
41725000 | shares |
CY2014 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
695000 | shares |
CY2015 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1772000 | shares |
CY2016 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
375000 | shares |
CY2016 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-1891000 | USD |
CY2016 | hbio |
Net Change In Income Tax Expense Benefit Resulting From Permanent Differences
NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences
|
-128000 | USD |
CY2015 | hbio |
Net Change In Income Tax Expense Benefit Resulting From Permanent Differences
NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences
|
32000 | USD |
CY2014 | hbio |
Net Change In Income Tax Expense Benefit Resulting From Permanent Differences
NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences
|
-93000 | USD |
CY2016 | hbio |
Net Impact Of Foreign Rate Changes
NetImpactOfForeignRateChanges
|
30000 | USD |
CY2015 | hbio |
Net Impact Of Foreign Rate Changes
NetImpactOfForeignRateChanges
|
89000 | USD |
CY2014 | hbio |
Net Impact Of Foreign Rate Changes
NetImpactOfForeignRateChanges
|
0 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
-89000 | USD |
CY2016 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
127000 | USD |
CY2015 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
35000 | USD |
CY2014 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
0 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
1000 | USD |
CY2016Q4 | hbio |
Deferred Tax Assets Tax Credits On Repatriation
DeferredTaxAssetsTaxCreditsOnRepatriation
|
0 | USD |
CY2015Q4 | hbio |
Deferred Tax Assets Tax Credits On Repatriation
DeferredTaxAssetsTaxCreditsOnRepatriation
|
1728000 | USD |
CY2016Q4 | hbio |
Deferred Tax Liabilities Indefinite Lived Intangible Assets
DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets
|
4567000 | USD |
CY2015Q4 | hbio |
Deferred Tax Liabilities Indefinite Lived Intangible Assets
DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets
|
4593000 | USD |
CY2016Q4 | hbio |
Deferred Tax Liabilities Definite Lived Intangible Assets
DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets
|
2593000 | USD |
CY2015Q4 | hbio |
Deferred Tax Liabilities Definite Lived Intangible Assets
DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets
|
2587000 | USD |
CY2016Q4 | hbio |
Deferred Tax Liabilities On Repatriation
DeferredTaxLiabilitiesOnRepatriation
|
0 | USD |
CY2015Q4 | hbio |
Deferred Tax Liabilities On Repatriation
DeferredTaxLiabilitiesOnRepatriation
|
1728000 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
291000 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-983000 | USD |
CY2015Q4 | hbio |
Additional Paid In Capital Net Operating Loss Impact On Deferred Tax Assets
AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets
|
900000 | USD |
CY2016 | hbio |
Defined Benefit Plan Increase Decrease In Discount Rate Percentage
DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage
|
0.001 | pure |
CY2016 | hbio |
Defined Benefit Plan Increase Decrease In Asset Return Percentage
DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage
|
0.001 | pure |
CY2016 | hbio |
Defined Benefit Plan Increase Decrease In Discount Rate Value
DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue
|
30000 | USD |
CY2016 | hbio |
Defined Benefit Plan Increase Decrease In Asset Return Value
DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue
|
163000 | USD |
CY2016 | hbio |
Defined Benefit Plan Average Pension Plan Liability
DefinedBenefitPlanAveragePensionPlanLiability
|
P15Y | |
CY2016 | hbio |
Defined Benefit Plan Average Remaining Work Lifetime
DefinedBenefitPlanAverageRemainingWorkLifetime
|
P15Y | |
CY2016Q4 | us-gaap |
Shares Issued
SharesIssued
|
42187000 | shares |
CY2016Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
15746000 | USD |
CY2016Q4 | us-gaap |
Assets
Assets
|
107765000 | USD |
CY2016Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
1209000 | USD |
CY2016Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
4175000 | USD |
CY2016Q4 | us-gaap |
Inventory Net
InventoryNet
|
19955000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
1157000 | USD |
CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
17471000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
0 | USD |
CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
45472000 | USD |
CY2016Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
128000 | USD |
CY2016Q4 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
2372000 | USD |
CY2016Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
6196000 | USD |
CY2016Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
500000 | USD |
CY2016Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
223000 | USD |
CY2016Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4550000 | USD |
CY2016Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
760000 | USD |
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
14601000 | USD |
CY2016Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
11374000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
6417000 | USD |
CY2016Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
3177000 | USD |
CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
35569000 | USD |
CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
418000 | USD |
CY2016Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
215134000 | USD |
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-116030000 | USD |
CY2016Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-16658000 | USD |
CY2016Q4 | us-gaap |
Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
|
10668000 | USD |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
107765000 | USD |
CY2016Q4 | us-gaap |
Goodwill
Goodwill
|
38032000 | USD |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
72196000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
|
0 | USD |
CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4296000 | USD |
CY2016 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
39000 | USD |
CY2015 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
93000 | USD |
CY2016Q4 | us-gaap |
Defined Benefit Plan Weighted Average Asset Allocations
DefinedBenefitPlanWeightedAverageAssetAllocations
|
1 | pure |
CY2016Q3 | us-gaap |
Revenues
Revenues
|
25007000 | USD |
CY2015Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1401000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
130000 | USD |
CY2016Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
9340000 | USD |
CY2016Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
823000 | USD |
CY2016Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
9792000 | USD |
CY2015Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
10957000 | USD |
CY2015Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
888000 | USD |
CY2015Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
10498000 | USD |
CY2013Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
305000 | USD |
CY2014Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
252000 | USD |
CY2014Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
252000 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Benefits Paid
DefinedBenefitPlanBenefitsPaid
|
-1021000 | USD |
CY2015 | us-gaap |
Defined Benefit Plan Contributions By Plan Participants
DefinedBenefitPlanContributionsByPlanParticipants
|
0 | USD |
CY2015Q4 | us-gaap |
Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
|
18582000 | USD |
CY2016Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
611000 | USD |
CY2016 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
309000 | USD |
CY2016Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
758000 | USD |
CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1638000 | USD |
CY2016Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | |
CY2016Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | |
CY2015Q1 | us-gaap |
Revenues
Revenues
|
25763000 | USD |
CY2015Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
14285000 | USD |
CY2015Q1 | us-gaap |
Gross Profit
GrossProfit
|
11478000 | USD |
CY2015Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
12628000 | USD |
CY2015Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1150000 | USD |
CY2015Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-614000 | USD |
CY2015Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1764000 | USD |
CY2016Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
12503000 | USD |
CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-813000 | USD |
CY2016Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-67000 | USD |
CY2016Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-880000 | USD |
CY2016 | us-gaap |
Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
|
11000 | USD |
CY2016 | hbio |
Valuation Allowances And Reserves Currency Translation
ValuationAllowancesAndReservesCurrencyTranslation
|
-19000 | USD |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5596000 | USD |
CY2016Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
611000 | USD |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
80000000 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
42186827 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
34441320 | shares |
CY2016Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
7745507 | shares |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2016 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
|
52000 | USD |
CY2016 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
|
-88000 | USD |
CY2014 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
2156000 | USD |
CY2016 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
3497000 | USD |
CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4307000 | USD |
CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19039000 | USD |
CY2015 | us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
0 | USD |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
3.15 | |
CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5351621 | shares |
CY2015 | hbio |
Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
|
2.12 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
43000 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
-593596 | shares |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4096818 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
3.89 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.92 | |
CY2016 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
5.31 | |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
4.15 | |
CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
3.04 | |
CY2015Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
3.85 | |
CY2015 | hbio |
Annualized Estimated Forfeiture Rate
AnnualizedEstimatedForfeitureRate
|
0.0806 | pure |
CY2014Q4 | hbio |
Non Qualified Stock Options Granted To Date
NonQualifiedStockOptionsGrantedToDate
|
12143374 | shares |
CY2016 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
676000 | USD |
CY2015 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | USD |
CY2014 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | USD |
CY2016 | us-gaap |
Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
|
1190000 | USD |
CY2015 | us-gaap |
Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
|
0 | USD |
CY2014 | us-gaap |
Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
|
0 | USD |
CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-3078000 | USD |
CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-3608000 | USD |
CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
4417000 | USD |
CY2015 | us-gaap |
Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
|
372000 | USD |
CY2016 | us-gaap |
Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
|
-484000 | USD |
CY2016 | us-gaap |
Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
|
50000 | USD |
CY2016 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
928000 | USD |
CY2015 | us-gaap |
Interest Paid
InterestPaid
|
854000 | USD |
CY2015Q4 | hbio |
Cash In Foreign Subsidiaries
CashInForeignSubsidiaries
|
5700000 | USD |
CY2014 | us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
0 | USD |
CY2015 | us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
0 | USD |
CY2016 | us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
1417000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
|
29000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
|
52000 | USD |
CY2016 | hbio |
Current Federal And State Income Tax Expense Benefit Continuing Operations
CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
|
170000 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
|
497000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
|
0 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
|
0 | USD |
CY2016 | hbio |
Income Tax Reconciliation Foreign Operations Foreign Withholding Taxes
IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes
|
74000 | USD |
CY2015 | hbio |
Income Tax Reconciliation Foreign Operations Foreign Withholding Taxes
IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes
|
0 | USD |
CY2014 | hbio |
Income Tax Reconciliation Foreign Operations Foreign Withholding Taxes
IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes
|
0 | USD |
CY2016 | hbio |
Income Tax Reconciliation Foreign Tax Credits Deduction
IncomeTaxReconciliationForeignTaxCreditsDeduction
|
1772000 | USD |
CY2015 | hbio |
Income Tax Reconciliation Foreign Tax Credits Deduction
IncomeTaxReconciliationForeignTaxCreditsDeduction
|
0 | USD |
CY2014 | hbio |
Income Tax Reconciliation Foreign Tax Credits Deduction
IncomeTaxReconciliationForeignTaxCreditsDeduction
|
0 | USD |
CY2016 | hbio |
Income Tax Reconciliation Loss On Subsidiary Stock Sale
IncomeTaxReconciliationLossOnSubsidiaryStockSale
|
501000 | USD |
CY2015 | hbio |
Income Tax Reconciliation Loss On Subsidiary Stock Sale
IncomeTaxReconciliationLossOnSubsidiaryStockSale
|
0 | USD |
CY2014 | hbio |
Income Tax Reconciliation Loss On Subsidiary Stock Sale
IncomeTaxReconciliationLossOnSubsidiaryStockSale
|
0 | USD |
CY2016Q4 | hbio |
Undistributed Foreign Earnings
UndistributedForeignEarnings
|
48600000 | USD |
CY2016Q4 | hbio |
Additional Paid In Capital Net Operating Loss Impact On Deferred Tax Assets
AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets
|
0 | USD |
CY2016 | hbio |
Income Tax Rate Reconciliation Deductions Stock Options
IncomeTaxRateReconciliationDeductionsStockOptions
|
1600000 | USD |
CY2015 | hbio |
Income Tax Rate Reconciliation Deductions Stock Options
IncomeTaxRateReconciliationDeductionsStockOptions
|
1600000 | USD |
CY2016 | hbio |
Business Acquisition Direct Acquisition Costs In Income Statement
BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement
|
0 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
5000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
18000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2076000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1491000 | USD |
CY2016Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
59000 | USD |
CY2016Q4 | us-gaap |
Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
|
200000 | USD |
CY2016 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
59000 | USD |
CY2016Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
-104000 | USD |
CY2015Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
-167000 | USD |
CY2016 | dei |
Document Type
DocumentType
|
10-K | |
CY2016 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2016-12-31 | |
CY2015Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
35000 | USD |
CY2016 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2016 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2016 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2016 | |
CY2016 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2016 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001123494 | |
CY2016 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2016 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2016 | dei |
Entity Registrant Name
EntityRegistrantName
|
HARVARD BIOSCIENCE INC | |
CY2016 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2016 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2016 | dei |
Trading Symbol
TradingSymbol
|
HBIO | |
CY2017Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
34582588 | shares |
CY2016Q2 | dei |
Entity Public Float
EntityPublicFloat
|
89715296 | USD |
CY2016Q2 | hbio |
Non Affiliate Share Holding
NonAffiliateShareHolding
|
31368985 | shares |